2025年6月 致编辑的信
June 2025 Letters to the Editor.
作者信息
Mohler Caitlin, Hartings Elizabeth, Penwell Heather, Brown Robin, O’Malley Patricia, Breckenridge-Trotter Tanya, Hall Holly, Reynolds Emily, Lindsey Leslie, Carr Anna, Shapiro Marti, Elliott Sara, Long Jennifer, Drake Annette, Robinson Danielle, Crump Gail, Macsay Erin
出版信息
Clin J Oncol Nurs. 2025 May 19;29(3):E103-E109. doi: 10.1188/25.CJON.E103-E109.
Abstract
Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questio.
摘要
决定发表哪些信件由编辑做出。信件若要被接受，必须署名。若作者要求，信件可以匿名发表。所有信件都需经过编辑。一封质疑的信件。 （原文最后似乎不完整）
相似文献
1
June 2025 Letters to the Editor.2025年6月 致编辑的信
Clin J Oncol Nurs. 2025 May 19;29(3):E103-E109. doi: 10.1188/25.CJON.E103-E109.
2
Challenges associated with hereditary cancer susceptibility testing.与遗传性癌症易感性检测相关的挑战。
Clin J Oncol Nurs. 2014 Feb;18(1):14-5. doi: 10.1188/14.CJON.14-15.
3
What is the role of 'the letter to the editor'?“致编辑的信”的作用是什么？
Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2089-93. doi: 10.1007/s00405-014-3289-7. Epub 2014 Sep 18.
4
Writing a letter to the Editor.写一封给编辑的信。
Singapore Med J. 2010 Jul;51(7):532-5.
5
Letters to the editor: definitely not children of a lesser god.致编辑的信：绝对不是次等神灵的孩子。
Int Angiol. 2009 Oct;28(5):418-20.
6
A quantitative study of letters to the editor by medical students in medical education journals.对医学教育期刊中学生投稿信的定量研究。
Med Educ Online. 2021 Dec;26(1):1912879. doi: 10.1080/10872981.2021.1912879.
7
Letters to the editor 1991. An audit of the MJA's correspondence columns.致编辑的信 1991 年。对《澳大利亚医学杂志》读者来信专栏的一次审核。
Med J Aust. 1992 Jul 6;157(1):63-4.
8
[Frequency and characteristics of letters to the editor published in Farmacia Hospitalaria (1995-2006)].[发表于《医院药学》（1995 - 2006年）的读者来信的频率及特点]
Farm Hosp. 2007 May-Jun;31(3):156-60. doi: 10.1016/s1130-6343(07)75363-1.
9
The challenges of editorship: a reflection on editing the Jung-Neumann correspondence.编辑工作的挑战：对编辑荣格与诺伊曼通信的思考
J Anal Psychol. 2016 Apr;61(2):155-71. doi: 10.1111/1468-5922.12210.
10
Automatic adverse drug events detection using letters to the editor.利用读者来信进行药物不良事件自动检测
AMIA Annu Symp Proc. 2012;2012:1030-9. Epub 2012 Nov 3.
本文引用的文献
1
Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.采用改良 Markman 输注方案作为主要预防措施的紫杉醇过敏反应发生率。
Support Care Cancer. 2024 Apr 17;32(5):292. doi: 10.1007/s00520-024-08460-z.
2
Standardized Titration Protocol Reduces the Incidence of Paclitaxel Infusion-Related Hypersensitivity Reactions.标准化滴定方案可降低紫杉醇输注相关性过敏反应的发生率。
JCO Oncol Pract. 2023 Dec;19(12):1199-1205. doi: 10.1200/OP.23.00225. Epub 2023 Oct 31.
3
Hypersensitivity Reactions: Practice Recommendations for Paclitaxel Administration.过敏反应：紫杉醇给药的实践推荐。
Clin J Oncol Nurs. 2021 Dec 1;25(6):713-716. doi: 10.1188/21.CJON.713-716.
4
Hypersensitivity Reactions to Platinum Agents and Taxanes.铂类药物和紫杉烷类药物的过敏反应。
Clin Rev Allergy Immunol. 2022 Jun;62(3):432-448. doi: 10.1007/s12016-021-08877-y. Epub 2021 Aug 2.
5
Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.紫杉醇单药治疗的临床药代动力学：一项更新的文献综述。
Clin Pharmacokinet. 2018 Jan;57(1):7-19. doi: 10.1007/s40262-017-0563-z.
6
Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations.铂类和紫杉烷类化疗药物过敏的管理：Cepo 综述和临床建议。
Curr Oncol. 2014 Aug;21(4):e630-41. doi: 10.3747/co.21.1966.
7
One-hour paclitaxel infusions: review of safety and efficacy.一小时紫杉醇输注：安全性与疗效综述
Cancer J Sci Am. 1999 May-Jun;5(3):179-91.
8
Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.1小时输注给药的紫杉醇：一项比较两种给药方案的I-II期试验。
Cancer J Sci Am. 1995 Nov-Dec;1(4):281-7.
Zotero 插件